Identification of a novel 17,000-dalton parathyroid hormone-like adenylate cyclase-stimulating protein from a tumor associated with humoral hypercalcemia of malignancy.
Identification of a novel 17,000-dalton parathyroid hormone-like adenylate cyclase-stimulating protein from a tumor associated with humoral hypercalcemia of malignancy.
复制标题
DOI:
10.1016/s0021-9258(18)48217-8
复制
发表时间:
1987-05
期刊:
影响因子:
--
通讯作者:
W. Burtis;T. Wu;C. Bunch;J. Wysolmerski;K. Insogna;E. C. Weir;A. Broadus;A. F. Stewart
中科院分区:
文献类型:
--
作者:
W. Burtis;T. Wu;C. Bunch;J. Wysolmerski;K. Insogna;E. C. Weir;A. Broadus;A. F. Stewart
Humoral hypercalcemia of malignancy is a common paraneoplastic syndrome which is characterized by hypercalcemia resulting from secretion by tumors of a circulating bone-resorbing factor. Evidence suggests that in many instances this factor is an adenylate cyclase-stimulating protein which shares features with, but is distinct from, parathyroid hormone (PTH). The current report describes the purification to homogeneity from a humoral hypercalcemia of malignancy-associated tumor of a novel, basic, highly potent PTH-like adenylate cyclase-stimulating protein. This factor differs from previously described PTH-like factors with respect to size, amino acid composition, and specific activity.